Finasteride Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062984
  • May 2021
  • Pharmaceuticals
  • 128 Pages
The Finasteride Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Zhejiang CONBA Pharmaceutical, Merck, Cipla, Sandoz, Teva Pharmaceuticals, RelonChem, Henan Topfond, Actavis, Accord Pharmaceuticals, Mylan N.V.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Finasteride market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Finasteride market is expected to attain Pre COVID-19 levels by mid-2022.

Finasteride Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Finasteride market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Finasteride Market Competitive and Premeditated Analysis
In the Finasteride report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Finasteride research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Finasteride Market:
The Finasteride market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Zhejiang CONBA Pharmaceutical, Merck, Cipla, Sandoz, Teva Pharmaceuticals, RelonChem, Henan Topfond, Actavis, Accord Pharmaceuticals, Mylan N.V.

The Finasteride market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Finasteride Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Finasteride market:
By Dosage
1mg
5mg
Application
Prostate Enlargement
Prostate Cancer
Scalp Hair Loss
Excessive Hair Growth
Hormone Therapy
Others
Distribution Channel
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies

Regional Analysis of the Finasteride market:
The Finasteride market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Finasteride report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Finasteride market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Finasteride market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Finasteride market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Finasteride market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Finasteride market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Finasteride market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Finasteride market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Finasteride market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Zhejiang CONBA Pharmaceutical
  • Merck
  • Cipla
  • Sandoz
  • Teva Pharmaceuticals
  • RelonChem
  • Henan Topfond
  • Actavis
  • Accord Pharmaceuticals
  • Mylan N.V.
  • 1mg
  • 5mg
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Finasteride Market Snapshot
          2.1.1. Global Finasteride Market By Dosage,2019
               2.1.1.1.1mg
               2.1.1.2.5mg
          2.1.2. Global Finasteride Market By Distribution Channel,2019
               2.1.2.1.Retail Pharmacies
               2.1.2.2.Online Pharmacies
               2.1.2.3.Hospital Pharmacies
          2.1.3. Global Finasteride Market By End-use,2019
          2.1.4. Global Finasteride Market By Geography,2019

3. Global Finasteride Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Finasteride Market Size (US$), By Dosage, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Dosage, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Dosage, 2020
     4.2. Global Finasteride Market Size (US$), By Dosage, 2018 – 2028

5. Global Finasteride Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Finasteride Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Finasteride Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Finasteride Market Size (US$), By End-use, 2018 – 2028

7. Global Finasteride Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Finasteride Market Analysis, 2018 – 2028 
          7.2.1. North America Finasteride Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Finasteride Market Size (US$), By Dosage, 2018 – 2028
          7.2.3. North America Finasteride Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Finasteride Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Finasteride Market Analysis, 2018 – 2028 
          7.3.1.  Europe Finasteride Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Finasteride Market Size (US$), By Dosage, 2018 – 2028
          7.3.3. Europe Finasteride Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Finasteride Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Finasteride Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Finasteride Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Finasteride Market Size (US$), By Dosage, 2018 – 2028
          7.4.3. Asia Pacific Finasteride Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Finasteride Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Finasteride Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Finasteride Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Finasteride Market Size (US$), By Dosage, 2018 – 2028
          7.5.3. Latin America Finasteride Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Finasteride Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Finasteride Market Analysis, 2018 – 2028 
          7.6.1.  MEA Finasteride Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Finasteride Market Size (US$), By Dosage, 2018 – 2028
          7.6.3. MEA Finasteride Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Finasteride Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Finasteride Providers
        8.4.1 Zhejiang CONBA Pharmaceutical
                8.4.1.1 Business Description
                8.4.1.2 Zhejiang CONBA Pharmaceutical Geographic Operations
                8.4.1.3 Zhejiang CONBA Pharmaceutical Financial Information
                8.4.1.4 Zhejiang CONBA Pharmaceutical Product Positions/Portfolio
                8.4.1.5 Zhejiang CONBA Pharmaceutical Key Developments
        8.4.2 Merck
                8.4.2.1 Business Description
                8.4.2.2 Merck Geographic Operations
                8.4.2.3 Merck Financial Information
                8.4.2.4 Merck Product Positions/Portfolio
                8.4.2.5 Merck Key Developments
        8.4.3 Cipla
                8.4.3.1 Business Description
                8.4.3.2 Cipla Geographic Operations
                8.4.3.3 Cipla Financial Information
                8.4.3.4 Cipla Product Positions/Portfolio
                8.4.3.5 Cipla Key Developments
        8.4.4 Sandoz
                8.4.4.1 Business Description
                8.4.4.2 Sandoz Geographic Operations
                8.4.4.3 Sandoz Financial Information
                8.4.4.4 Sandoz Product Positions/Portfolio
                8.4.4.5 Sandoz Key Developments
        8.4.5 Teva Pharmaceuticals
                8.4.5.1 Business Description
                8.4.5.2 Teva Pharmaceuticals Geographic Operations
                8.4.5.3 Teva Pharmaceuticals Financial Information
                8.4.5.4 Teva Pharmaceuticals Product Positions/Portfolio
                8.4.5.5 Teva Pharmaceuticals Key Developments
        8.4.6 RelonChem
                8.4.6.1 Business Description
                8.4.6.2 RelonChem Geographic Operations
                8.4.6.3 RelonChem Financial Information
                8.4.6.4 RelonChem Product Positions/Portfolio
                8.4.6.5 RelonChem Key Developments
        8.4.7 Henan Topfond
                8.4.7.1 Business Description
                8.4.7.2 Henan Topfond Geographic Operations
                8.4.7.3 Henan Topfond Financial Information
                8.4.7.4 Henan Topfond Product Positions/Portfolio
                8.4.7.5 Henan Topfond Key Developments
        8.4.8 Actavis
                8.4.8.1 Business Description
                8.4.8.2 Actavis Geographic Operations
                8.4.8.3 Actavis Financial Information
                8.4.8.4 Actavis Product Positions/Portfolio
                8.4.8.5 Actavis Key Developments
        8.4.9 Accord Pharmaceuticals
                8.4.9.1 Business Description
                8.4.9.2 Accord Pharmaceuticals Geographic Operations
                8.4.9.3 Accord Pharmaceuticals Financial Information
                8.4.9.4 Accord Pharmaceuticals Product Positions/Portfolio
                8.4.9.5 Accord Pharmaceuticals Key Developments
        8.4.10 Mylan N.V.
                8.4.10.1 Business Description
                8.4.10.2 Mylan N.V. Geographic Operations
                8.4.10.3 Mylan N.V. Financial Information
                8.4.10.4 Mylan N.V. Product Positions/Portfolio
                8.4.10.5 Mylan N.V. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Finasteride Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Finasteride Market Revenue, By Dosage, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Finasteride Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Finasteride Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Finasteride Market Revenue, By Dosage, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Finasteride Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Finasteride Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Finasteride Market Revenue, By Dosage, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Finasteride Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Finasteride Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Finasteride Market Revenue, By Dosage, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Finasteride Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Finasteride Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Finasteride Market Revenue, By Dosage, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Finasteride Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Finasteride Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Finasteride: Market Segmentation 
FIG. 2 Global Finasteride Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Finasteride Market, By Dosage, 2019 (US$ Mn) 
FIG. 5 Global Finasteride Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Finasteride Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Finasteride Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Finasteride Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Finasteride Providers, 2019
FIG. 11 Global Finasteride Market Revenue Contribution, By Dosage, 2019 & 2028 (Value %) 
FIG. 12 Global Finasteride Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Finasteride Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Finasteride Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Finasteride Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Finasteride Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Finasteride Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Finasteride Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Finasteride market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Finasteride Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Finasteride Market Value, By Segment1, 2018 – 2028
TABLE  North America Finasteride Market Value, By Segment2, 2018 – 2028
TABLE  North America Finasteride Market Value, By Country, 2018 – 2028
TABLE  Europe Finasteride Market Value, By Segment1, 2018 – 2028
TABLE  Europe Finasteride Market Value, By Segment2, 2018 – 2028
TABLE  Europe Finasteride Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Finasteride Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Finasteride Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Finasteride Market Value, By Country, 2018 – 2028
TABLE  Latin America Finasteride Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Finasteride Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Finasteride Market Value, By Country, 2018 – 2028
TABLE  MEA Finasteride Market Value, By Segment1, 2018 – 2028
TABLE  MEA Finasteride Market Value, By Segment2, 2018 – 2028
TABLE  MEA Finasteride Market Value, By Country, 2018 – 2028
TABLE  Zhejiang CONBA Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sandoz: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  RelonChem: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Henan Topfond: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Actavis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Accord Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Finasteride Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Finasteride Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Finasteride Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Finasteride Market, By Geography, 2019 (US$ Mn)
FIG.  Global Finasteride Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Finasteride Providers, 2016
FIG.  Global Finasteride Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global 5mg Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Finasteride Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Online Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hospital Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Finasteride Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Finasteride Market Value, 2018 – 2028, (US$ Mn)